HomeNewsOpinionCOVID-19 | Countermeasures adopted by nations must factor in the vulnerabilities of refugees as well

COVID-19 | Countermeasures adopted by nations must factor in the vulnerabilities of refugees as well

The geopolitical and geo-economical backdrop of coronavirus makes refugee health protection a critical public health priority.

April 06, 2020 / 13:32 IST
Story continues below Advertisement

Adithya Anil Variath

The myth of the universalist liberal order amidst the novel coronavirus (COVID-19) outbreak is caught between two paradoxes: the universal responsibility to protect the human rights and the inexorable demand to reassert the Westphalian model of sovereignty to enhance and maximise healthcare needs of their relative population. This institutional approach of the governments and health systems would disproportionately defile the socially-excluded and powerless members of the global order — the refugees. In the post-modern global order, refugees make up the most vulnerable section of society.

Story continues below Advertisement

In 2019, there were 20.4 million refugees under the mandate of the UNHCR. Across the world, around 70.8 million people are forcibly displaced. Overcrowding, malnutrition and poor access to healthcare services are already leading to higher morbidity and mortality rates among refugee and displaced populations. Yet, countermeasures adopted by countries during this outbreak have failed to take into account the vulnerability of refugees.

The pandemic has infected more than 1,202,242 people and with at least 64,729 fatalities. A pandemic of this severity poses a threat to global health and to upholding human rights.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show